Bicara Therapeutics Inc. (BCAX)
NASDAQ: BCAX · Real-Time Price · USD
16.55
+0.80 (5.08%)
Mar 7, 2025, 4:00 PM EST - Market closed
Bicara Therapeutics Analyst Ratings
Total Analysts
6
Consensus Rating
Strong Buy
Price Target
$39.50
Upside
+138.67%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Reiterates $31 | Buy | Reiterates | $31 | +87.31% | Feb 12, 2025 |
| Wedbush | Wedbush | Buy Initiates $31 | Buy | Initiates | $31 | +87.31% | Feb 6, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $42 → $45 | Strong Buy | Maintains | $42 → $45 | +171.90% | Jan 27, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $42 | Strong Buy | Initiates | $42 | +153.78% | Dec 6, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Oct 8, 2024 |
| Stifel | Stifel | Strong Buy Initiates $47 | Strong Buy | Initiates | $47 | +183.99% | Oct 8, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $35 | Buy | Initiates | $35 | +111.48% | Oct 8, 2024 |
| TD Cowen | TD Cowen | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Oct 8, 2024 |